Evidence map›Paper›PMID 32699352›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1.

Dominic Lenz, Desirée E C Smith, Ellen Crushell, Ralf A Husain, Gajja S Salomons, Bader Alhaddad, Jonathan A Bernstein, Alyssa Bianzano, Saskia Biskup, Heiko Brennenstuhl and 30 more

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Phenotype and Long-Term Outcome in Recurrent Paediatric Acute Liver Failure: Systematic Review and Individual Participant Data Analysis.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Pooled it
  2. Current status in paediatric liver transplantation for inherited metabolic diseases.Journal of pediatric gastroenterology and nutrition · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Goldilocks principle and recessive disease.European journal of human genetics : EJHG · 2024
    Article
  14. Review
  15. Article
  16. Expanded phenotype of AARS1-related white matter disease.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 17 institutions in 6 countries.

Dominic LenzDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Desirée E C SmithMetabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam, The Netherlands.
Ellen CrushellNational Centre for Inherited Metabolic Disorders, Children's Health Ireland at Temple Street and Crumlin, Dublin, Ireland.
Ralf A HusainCentre for Inborn Metabolic Disorders, Department of Neuropediatrics, Jena University Hospital, Jena, Germany.
Gajja S SalomonsMetabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam, The Netherlands.
Bader AlhaddadInstitute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Jonathan A BernsteinDepartment of Pediatrics, Stanford School of Medicine, Stanford, CA, USA.
Alyssa BianzanoDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Saskia BiskupCeGaT GmbH, Tübingen, Germany.
Heiko BrennenstuhlDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Dominique CaldariService de pédiatrie, CHU Nantes, Nantes, France.
Nicola DikowInstitute of Human Genetics, Heidelberg University, Heidelberg, Germany.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Andrea Hanson-KahnDepartment of Genetics, Stanford University School of Medicine, Palo Alto, CA, USA.
Inga HartingDepartment of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
Denise HornInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Joanne HughesNational Centre for Inherited Metabolic Disorders, Children's Health Ireland at Temple Street and Crumlin, Dublin, Ireland.
Maya HuijbertsDepartment of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Bertrand IsidorService de Génétique Médicale, CHU Nantes, Nantes, France.
Simone KathemannChildren's Hospital, Department of Pediatric Gastroenterology, Hepatology, and Transplant Medicine, University Duisburg-Essen, Essen, Germany.
Robert KopajtichInstitute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Urania KotzaeridouDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Sébastien KüryService de Génétique Médicale, CHU Nantes, Nantes, France.
Elke LainkaChildren's Hospital, Department of Pediatric Gastroenterology, Hepatology, and Transplant Medicine, University Duisburg-Essen, Essen, Germany.
Lucia LaugwitzInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Claire ReynoldsNational Centre for Inherited Metabolic Disorders, Children's Health Ireland at Temple Street and Crumlin, Dublin, Ireland.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Julian SchröterDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Fleur VansenneDepartment of Clinical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Matias WagnerInstitute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Claudia WeißDepartment of Neuropediatrics, Sozialpädiatrisches Zentrum (SPZ), Center for Chronically Sick Children, Charité-Universitätsmedizin Berlin, Germany, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Bruce H R WolffenbuttelDepartment of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Saskia B WortmannInstitute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Stefan KölkerDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Georg F HoffmannDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Holger ProkischInstitute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Marisa I MendesMetabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam, The Netherlands.
Christian StaufnerDivision of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany. Christian.Staufner@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-1403-9075
Heidelberg University · DETUM Klinikum · DEAmsterdam Neuroscience · NLBaylor College of Medicine · USChildren's Health Ireland at Crumlin · IEUniversity Medical Center Groningen · NLCentre National de la Recherche Scientifique · FRUniversity of Duisburg-Essen · DEUniversity of Tübingen · DECentre Hospitalier Universitaire de Nantes · FRCharité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DEJena University Hospital · DELucile Packard Children's Hospital · USParacelsus Medical University · ATPraxis für Humangenetik Tübingen · DEStanford Medicine · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASER35NS105078 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2018 to 2025
$6.0M
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset diseaseK08HG008986 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI POSEY, JENNIFER ELLEN · 2017 to 2021
$831k
NHGRI NIH HHS K08 HG008986NHGRI NIH HHS UM1 HG006542NINDS NIH HHS R35 NS105078
6 · The paper itself

Abstract

purposeBiallelic variants in LARS1, coding for the cytosolic leucyl-tRNA synthetase, cause infantile liver failure syndrome 1 (ILFS1). Since its description in 2012, there has been no systematic analysis of the clinical spectrum and genetic findings.

methodsIndividuals with biallelic variants in LARS1 were included through an international, multicenter collaboration including novel and previously published patients. Clinical variables were analyzed and functional studies were performed in patient-derived fibroblasts.

resultsTwenty-five individuals from 15 families were ascertained including 12 novel patients with eight previously unreported variants. The most prominent clinical findings are recurrent elevation of liver transaminases up to liver failure and encephalopathic episodes, both triggered by febrile illness. Magnetic resonance image (MRI) changes during an encephalopathic episode can be consistent with metabolic stroke. Furthermore, growth retardation, microcytic anemia, neurodevelopmental delay, muscular hypotonia, and infection-related seizures are prevalent. Aminoacylation activity is significantly decreased in all patient cells studied upon temperature elevation in vitro.

conclusionILFS1 is characterized by recurrent elevation of liver transaminases up to liver failure in conjunction with abnormalities of growth, blood, nervous system, and musculature. Encephalopathic episodes with seizures can occur independently from liver crises and may present with metabolic stroke.

Indexed as

Liver FailureHumansMuscle HypotoniaMutationSeizuresacute liver failureaminoacyl-tRNA synthetase deficiencyinfantile liver failure syndrome type 1LARS1metabolic stroke

Identifiers

PMID32699352
OpenAlexW3045046928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.